Intellectual Property Magazine
Leading Covid-19 vaccine firm issues exclusivity warning
Ben Wodecki
Biotech firm Moderna Therapeutics, which is working withAstraZeneca and the University of Oxford to create a Covid-19 vaccine,
haswarned investors that revenue losses could be expected should it fail to obtainregulatory exclusivities and broad patent
scope on any potential vaccine.